Background
tumors, pancreatic adenocarcinoma
TUMORS, PANCREATIC ADENOCARCINOMA
Neoadjuvant treatment with nab‐paclitaxel and gemcitabine for potentially operable pancreatic adenocarcinoma has not been well studied in a prospective interventional trial and could down‐stage tumors to achieve negative surgical margins.